This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Small study offers hope for Alzheimer's drug
A Baxter International six month study of its intravenous immune therapy Gammagard in 24 elderly patients shows preliminary memory improvements and signals potential to slow Alzheimer’s progression. Experts caution the study is small, but see parallels to AIDS era research and a push to develop immune based treatments with FDA trial design forthcoming.
MENTIONED IN THIS ARTICLE
Chicago
Baxter International Inc
National Institutes of Health
Baxter
David Bennett
Rush Alzheimer’s Diseases Center
Rush University Medical Center
Bennett
New Jersey
Wyeth
Elan Corp
FDA